Perhaps this isn’t in scope, but if I were designing a reading list on “lab governance”, I would try to include at least 1-2 perspectives that highlight the limitations of lab governance, criticisms of focusing too much on lab governance, etc.
Specific examples might include criticisms of RSPs, Kelsey’s coverage of the OpenAI NDA stuff, alleged instances of labs or lab CEOs misleading the public/policymakers, and perspectives from folks like Tegmark and Leahy (who generally see a lot of lab governance as safety-washing and probably have less trust in lab CEOs than the median AIS person).
(Perhaps such perspectives get covered in other units, but part of me still feels like it’s pretty important for a lab governance reading list to include some of these more “fundamental” critiques of lab governance. Especially insofar as, broadly speaking, I think a lot of AIS folks were more optimistic about lab governance 1-3 years ago than they are now.)
Perhaps this isn’t in scope, but if I were designing a reading list on “lab governance”, I would try to include at least 1-2 perspectives that highlight the limitations of lab governance, criticisms of focusing too much on lab governance, etc.
Specific examples might include criticisms of RSPs, Kelsey’s coverage of the OpenAI NDA stuff, alleged instances of labs or lab CEOs misleading the public/policymakers, and perspectives from folks like Tegmark and Leahy (who generally see a lot of lab governance as safety-washing and probably have less trust in lab CEOs than the median AIS person).
(Perhaps such perspectives get covered in other units, but part of me still feels like it’s pretty important for a lab governance reading list to include some of these more “fundamental” critiques of lab governance. Especially insofar as, broadly speaking, I think a lot of AIS folks were more optimistic about lab governance 1-3 years ago than they are now.)